Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05183204
What this trial is testing

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Who this might be right for
Glioblastoma
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04049669
What this trial is testing

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Who this might be right for
GlioblastomaMedulloblastomaEpendymoma+1 more
Theodore S. Johnson 130
Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Not applicableEnded earlyNCT03287063
What this trial is testing

Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
University of Michigan Rogel Cancer Center 6
Early research (Phase 1)Active Not RecruitingNCT03535350
What this trial is testing

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Case Comprehensive Cancer Center 36
Very early researchStudy completedNCT02490930
What this trial is testing

A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma

Who this might be right for
GlioblastomaAnaplastic Astrocytoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 5
Early research (Phase 1)UnknownNCT04967690
What this trial is testing

A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM

Who this might be right for
Newly Diagnosed Glioblastoma
Double Bond Pharmaceutical AB 27
Testing effectiveness (Phase 2)Study completedNCT01591577
What this trial is testing

Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme

Who this might be right for
Newly Diagnosed Glioblastoma Multiforme
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06012695
What this trial is testing

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of Brain
Novelwise Pharmaceutical Corporation 79
Early research (Phase 1)Active Not RecruitingNCT04900792
What this trial is testing

A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma

Who this might be right for
GlioblastomaGlioblastoma Multiforme
Bryan Allen 16
Early research (Phase 1)Study completedNCT02378532
What this trial is testing

The Addition of Chloroquine to Chemoradiation for Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Maastricht Radiation Oncology 13
Early research (Phase 1)Study completedNCT03451799
What this trial is testing

Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma

Who this might be right for
GBMGlioblastoma
Jethro Hu 21
Testing effectiveness (Phase 2)Study completedNCT00165477
What this trial is testing

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
GlioblastomaGliosarcomaMalignant Gliomas
Dana-Farber Cancer Institute 23
Early research (Phase 1)Study completedNCT03072134
What this trial is testing

Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma

Who this might be right for
GliomaAnaplastic AstrocytomaAnaplastic Oligodendroglioma+5 more
Northwestern University 12
Large-scale testing (Phase 3)Looking for participantsNCT05271240
What this trial is testing

Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioma, Malignant+4 more
Northwell Health 432
Not applicableStudy completedNCT00704808
What this trial is testing

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 180
Early research (Phase 1)Study completedNCT02149225
What this trial is testing

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Immatics Biotechnologies GmbH 16
Not applicableStudy completedNCT00999622
What this trial is testing

Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma

Who this might be right for
Brain and Central Nervous System TumorsInfection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 104
Large-scale testing (Phase 3)Study completedNCT00943826
What this trial is testing

Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Hoffmann-La Roche 921
Not applicableLooking for participantsNCT06964815
What this trial is testing

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

Who this might be right for
GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
Istituto Oncologico Veneto IRCCS 110
Next Page